APO Research
Talk to an analyst

APO RESEARCH · REPORT

Intravenous Injection General Anesthesia Drugs

Compare research editions
View pricing & licenses

Selected research

Industry Research

Intravenous Injection General Anesthesia Drugs Industry Research Report 2026

22 December 2025137 pages

Choose your research edition.

Industry ResearchIntravenous Injection General Anesthesia Drugs Industry Research Report 2026137 pages · $2,950 USDIndustry Growth & TrendsGlobal Intravenous Injection General Anesthesia Drugs Industry Growth and Trends Forecast to 2032114 pages · $3,450 USDMarket StructureGlobal Intravenous Injection General Anesthesia Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Intravenous Injection General Anesthesia Drugs Market Outlook and Growth Opportunities 2026209 pages · $4,250 USDMarket Analysis & ForecastGlobal Intravenous Injection General Anesthesia Drugs Market Analysis and Forecast 2026-2032208 pages · $4,950 USD

Market perspective

The global Intravenous Injection General Anesthesia Drugs market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Intravenous Injection General Anesthesia Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Intravenous Injection General Anesthesia Drugs is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Intravenous Injection General Anesthesia Drugs is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Intravenous Injection General Anesthesia Drugs include Aspen Pharma, Hikma Pharmaceuticals, Maruishi, Maruishi, Piramal, AstraZeneca, AbbVie, Baxter Healthcare and B.Braun, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Intravenous Injection General Anesthesia Drugs market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Intravenous Injection General Anesthesia Drugs Market by Company

Aspen Pharma

Hikma Pharmaceuticals

Maruishi

Maruishi

Piramal

AstraZeneca

AbbVie

Baxter Healthcare

B.Braun

Fresenius-Kabi

China National Medicines Guorui Pharmaceutical Co.,Ltd.

Hengrui

Nhwa

Lunan Pharmaceutical Group Corporation

Xi'an Libang

Yichang Humanwell

Intravenous Injection General Anesthesia Drugs Segment by Type

Propofol

Sevoflurane

Remifentanil

Etomidate

Isoflurane

Other

Intravenous Injection General Anesthesia Drugs Segment by Application

Hopitals

Clinics

Others

Intravenous Injection General Anesthesia Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Intravenous Injection General Anesthesia Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Intravenous Injection General Anesthesia Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Intravenous Injection General Anesthesia Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Intravenous Injection General Anesthesia Drugs manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Intravenous Injection General Anesthesia Drugs by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Intravenous Injection General Anesthesia Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Intravenous Injection General Anesthesia Drugs Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Intravenous Injection General Anesthesia Drugs Sales (k units) of Manufacturers (2021-2026) Table 7. Global Intravenous Injection General Anesthesia Drugs Sales Market Share by Manufacturers (2021-2026) Table 8. Global Intravenous Injection General Anesthesia Drugs Revenue of Manufacturers (2021-2026) Table 9. Global Intravenous Injection General Anesthesia Drugs Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Intravenous Injection General Anesthesia Drugs Average Price (US$/unit) of Manufacturers (2021-2026) Table 11. Global Intravenous Injection General Anesthesia Drugs Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Intravenous Injection General Anesthesia Drugs, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Intravenous Injection General Anesthesia Drugs, Product Type & Application Table 14. Global Intravenous Injection General Anesthesia Drugs Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Intravenous Injection General Anesthesia Drugs by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. Aspen Pharma Company Information Table 19. Aspen Pharma Business Overview Table 20. Aspen Pharma Intravenous Injection General Anesthesia Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 21. Aspen Pharma Intravenous Injection General Anesthesia Drugs Product Portfolio Table 22. Aspen Pharma Recent Developments Table 23. Hikma Pharmaceuticals Company Information Table 24. Hikma Pharmaceuticals Business Overview Table 25. Hikma Pharmaceuticals Intravenous Injection General Anesthesia Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 26. Hikma Pharmaceuticals Intravenous Injection General Anesthesia Drugs Product Portfolio Table 27. Hikma Pharmaceuticals Recent Developments Table 28. Maruishi Company Information Table 29. Maruishi Business Overview Table 30. Maruishi Intravenous Injection General Anesthesia Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 31. Maruishi Intravenous Injection General Anesthesia Drugs Product Portfolio Table 32. Maruishi Recent Developments Table 33. Maruishi Company Information Table 34. Maruishi Business Overview Table 35. Maruishi Intravenous Injection General Anesthesia Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 36. Maruishi Intravenous Injection General Anesthesia Drugs Product Portfolio Table 37. Maruishi Recent Developments Table 38. Piramal Company Information Table 39. Piramal Business Overview Table 40. Piramal Intravenous Injection General Anesthesia Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 41. Piramal Intravenous Injection General Anesthesia Drugs Product Portfolio Table 42. Piramal Recent Developments Table 43. AstraZeneca Company Information Table 44. AstraZeneca Business Overview Table 45. AstraZeneca Intravenous Injection General Anesthesia Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 46. AstraZeneca Intravenous Injection General Anesthesia Drugs Product Portfolio Table 47. AstraZeneca Recent Developments Table 48. AbbVie Company Information Table 49. AbbVie Business Overview Table 50. AbbVie Intravenous Injection General Anesthesia Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 51. AbbVie Intravenous Injection General Anesthesia Drugs Product Portfolio Table 52. AbbVie Recent Developments Table 53. Baxter Healthcare Company Information Table 54. Baxter Healthcare Business Overview Table 55. Baxter Healthcare Intravenous Injection General Anesthesia Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 56. Baxter Healthcare Intravenous Injection General Anesthesia Drugs Product Portfolio Table 57. Baxter Healthcare Recent Developments Table 58. B.Braun Company Information Table 59. B.Braun Business Overview Table 60. B.Braun Intravenous Injection General Anesthesia Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 61. B.Braun Intravenous Injection General Anesthesia Drugs Product Portfolio Table 62. B.Braun Recent Developments Table 63. Fresenius-Kabi Company Information Table 64. Fresenius-Kabi Business Overview Table 65. Fresenius-Kabi Intravenous Injection General Anesthesia Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 66. Fresenius-Kabi Intravenous Injection General Anesthesia Drugs Product Portfolio Table 67. Fresenius-Kabi Recent Developments Table 68. China National Medicines Guorui Pharmaceutical Co.,Ltd. Company Information Table 69. China National Medicines Guorui Pharmaceutical Co.,Ltd. Business Overview Table 70. China National Medicines Guorui Pharmaceutical Co.,Ltd. Intravenous Injection General Anesthesia Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 71. China National Medicines Guorui Pharmaceutical Co.,Ltd. Intravenous Injection General Anesthesia Drugs Product Portfolio Table 72. China National Medicines Guorui Pharmaceutical Co.,Ltd. Recent Developments Table 73. Hengrui Company Information Table 74. Hengrui Business Overview Table 75. Hengrui Intravenous Injection General Anesthesia Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 76. Hengrui Intravenous Injection General Anesthesia Drugs Product Portfolio Table 77. Hengrui Recent Developments Table 78. Nhwa Company Information Table 79. Nhwa Business Overview Table 80. Nhwa Intravenous Injection General Anesthesia Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 81. Nhwa Intravenous Injection General Anesthesia Drugs Product Portfolio Table 82. Nhwa Recent Developments Table 83. Lunan Pharmaceutical Group Corporation Company Information Table 84. Lunan Pharmaceutical Group Corporation Business Overview Table 85. Lunan Pharmaceutical Group Corporation Intravenous Injection General Anesthesia Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 86. Lunan Pharmaceutical Group Corporation Intravenous Injection General Anesthesia Drugs Product Portfolio Table 87. Lunan Pharmaceutical Group Corporation Recent Developments Table 88. Xi'an Libang Company Information Table 89. Xi'an Libang Business Overview Table 90. Xi'an Libang Intravenous Injection General Anesthesia Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 91. Xi'an Libang Intravenous Injection General Anesthesia Drugs Product Portfolio Table 92. Xi'an Libang Recent Developments Table 93. Yichang Humanwell Company Information Table 94. Yichang Humanwell Business Overview Table 95. Yichang Humanwell Intravenous Injection General Anesthesia Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 96. Yichang Humanwell Intravenous Injection General Anesthesia Drugs Product Portfolio Table 97. Yichang Humanwell Recent Developments Table 98. Global Intravenous Injection General Anesthesia Drugs Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 99. Global Intravenous Injection General Anesthesia Drugs Sales by Region (2021-2026) & (k units) Table 100. Global Intravenous Injection General Anesthesia Drugs Sales Market Share by Region (2021-2026) Table 101. Global Intravenous Injection General Anesthesia Drugs Sales by Region (2027-2032) & (k units) Table 102. Global Intravenous Injection General Anesthesia Drugs Sales Market Share by Region (2027-2032) Table 103. Global Intravenous Injection General Anesthesia Drugs Revenue by Region (2021-2026) & (US$ Million) Table 104. Global Intravenous Injection General Anesthesia Drugs Revenue Market Share by Region (2021-2026) Table 105. Global Intravenous Injection General Anesthesia Drugs Revenue by Region (2027-2032) & (US$ Million) Table 106. Global Intravenous Injection General Anesthesia Drugs Revenue Market Share by Region (2027-2032) Table 107. North America Intravenous Injection General Anesthesia Drugs Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 108. North America Intravenous Injection General Anesthesia Drugs Sales by Country (2021-2026) & (k units) Table 109. North America Intravenous Injection General Anesthesia Drugs Sales by Country (2027-2032) & (k units) Table 110. North America Intravenous Injection General Anesthesia Drugs Revenue by Country (2021-2026) & (US$ Million) Table 111. North America Intravenous Injection General Anesthesia Drugs Revenue by Country (2027-2032) & (US$ Million) Table 112. Europe Intravenous Injection General Anesthesia Drugs Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 113. Europe Intravenous Injection General Anesthesia Drugs Sales by Country (2021-2026) & (k units) Table 114. Europe Intravenous Injection General Anesthesia Drugs Sales by Country (2027-2032) & (k units) Table 115. Europe Intravenous Injection General Anesthesia Drugs Revenue by Country (2021-2026) & (US$ Million) Table 116. Europe Intravenous Injection General Anesthesia Drugs Revenue by Country (2027-2032) & (US$ Million) Table 117. Asia Pacific Intravenous Injection General Anesthesia Drugs Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 118. Asia Pacific Intravenous Injection General Anesthesia Drugs Sales by Country (2021-2026) & (k units) Table 119. Asia Pacific Intravenous Injection General Anesthesia Drugs Sales by Country (2027-2032) & (k units) Table 120. Asia Pacific Intravenous Injection General Anesthesia Drugs Revenue by Country (2021-2026) & (US$ Million) Table 121. Asia Pacific Intravenous Injection General Anesthesia Drugs Revenue by Country (2027-2032) & (US$ Million) Table 122. South America Intravenous Injection General Anesthesia Drugs Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 123. South America Intravenous Injection General Anesthesia Drugs Sales by Country (2021-2026) & (k units) Table 124. South America Intravenous Injection General Anesthesia Drugs Sales by Country (2027-2032) & (k units) Table 125. South America Intravenous Injection General Anesthesia Drugs Revenue by Country (2021-2026) & (US$ Million) Table 126. South America Intravenous Injection General Anesthesia Drugs Revenue by Country (2027-2032) & (US$ Million) Table 127. Middle East and Africa Intravenous Injection General Anesthesia Drugs Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 128. Middle East and Africa Intravenous Injection General Anesthesia Drugs Sales by Country (2021-2026) & (k units) Table 129. Middle East and Africa Intravenous Injection General Anesthesia Drugs Sales by Country (2027-2032) & (k units) Table 130. Middle East and Africa Intravenous Injection General Anesthesia Drugs Revenue by Country (2021-2026) & (US$ Million) Table 131. Middle East and Africa Intravenous Injection General Anesthesia Drugs Revenue by Country (2027-2032) & (US$ Million) Table 132. Global Intravenous Injection General Anesthesia Drugs Sales by Type (2021-2026) & (k units) Table 133. Global Intravenous Injection General Anesthesia Drugs Sales by Type (2027-2032) & (k units) Table 134. Global Intravenous Injection General Anesthesia Drugs Sales Market Share by Type (2021-2026) Table 135. Global Intravenous Injection General Anesthesia Drugs Sales Market Share by Type (2027-2032) Table 136. Global Intravenous Injection General Anesthesia Drugs Revenue by Type (2021-2026) & (US$ Million) Table 137. Global Intravenous Injection General Anesthesia Drugs Revenue by Type (2027-2032) & (US$ Million) Table 138. Global Intravenous Injection General Anesthesia Drugs Revenue Market Share by Type (2021-2026) Table 139. Global Intravenous Injection General Anesthesia Drugs Revenue Market Share by Type (2027-2032) Table 140. Global Intravenous Injection General Anesthesia Drugs Price by Type (2021-2026) & (US$/unit) Table 141. Global Intravenous Injection General Anesthesia Drugs Price by Type (2027-2032) & (US$/unit) Table 142. Global Intravenous Injection General Anesthesia Drugs Sales by Application (2021-2026) & (k units) Table 143. Global Intravenous Injection General Anesthesia Drugs Sales by Application (2027-2032) & (k units) Table 144. Global Intravenous Injection General Anesthesia Drugs Sales Market Share by Application (2021-2026) Table 145. Global Intravenous Injection General Anesthesia Drugs Sales Market Share by Application (2027-2032) Table 146. Global Intravenous Injection General Anesthesia Drugs Revenue by Application (2021-2026) & (US$ Million) Table 147. Global Intravenous Injection General Anesthesia Drugs Revenue by Application (2027-2032) & (US$ Million) Table 148. Global Intravenous Injection General Anesthesia Drugs Revenue Market Share by Application (2021-2026) Table 149. Global Intravenous Injection General Anesthesia Drugs Revenue Market Share by Application (2027-2032) Table 150. Global Intravenous Injection General Anesthesia Drugs Price by Application (2021-2026) & (US$/unit) Table 151. Global Intravenous Injection General Anesthesia Drugs Price by Application (2027-2032) & (US$/unit) Table 152. Key Raw Materials Table 153. Raw Materials Key Suppliers Table 154. Intravenous Injection General Anesthesia Drugs Distributors List Table 155. Intravenous Injection General Anesthesia Drugs Customers List Table 156. Intravenous Injection General Anesthesia Drugs Industry Trends Table 157. Intravenous Injection General Anesthesia Drugs Industry Drivers Table 158. Intravenous Injection General Anesthesia Drugs Industry Restraints Table 159. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Intravenous Injection General Anesthesia Drugs Product Image Figure 5. Global Intravenous Injection General Anesthesia Drugs Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Intravenous Injection General Anesthesia Drugs Market Size (2021-2032) & (US$ Million) Figure 7. Global Intravenous Injection General Anesthesia Drugs Sales (2021-2032) & (k units) Figure 8. Global Intravenous Injection General Anesthesia Drugs Average Price (US$/unit) & (2021-2032) Figure 9. Propofol Product Image Figure 10. Sevoflurane Product Image Figure 11. Remifentanil Product Image Figure 12. Etomidate Product Image Figure 13. Isoflurane Product Image Figure 14. Other Product Image Figure 15. Hopitals Product Image Figure 16. Clinics Product Image Figure 17. Others Product Image Figure 18. Global Intravenous Injection General Anesthesia Drugs Revenue Share by Manufacturers in 2025 Figure 19. Global Manufacturers of Intravenous Injection General Anesthesia Drugs, Manufacturing Sites & Headquarters Figure 20. Global Top 5 and 10 Intravenous Injection General Anesthesia Drugs Players Market Share by Revenue in 2025 Figure 21. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 22. Global Intravenous Injection General Anesthesia Drugs Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 23. Global Intravenous Injection General Anesthesia Drugs Sales by Region in 2025 Figure 24. Global Intravenous Injection General Anesthesia Drugs Revenue by Region in 2025 Figure 25. North America Intravenous Injection General Anesthesia Drugs Market Size by Country in 2025 Figure 26. North America Intravenous Injection General Anesthesia Drugs Sales Market Share by Country (2021-2032) Figure 27. North America Intravenous Injection General Anesthesia Drugs Revenue Market Share by Country (2021-2032) Figure 28. United States Intravenous Injection General Anesthesia Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 29. Canada Intravenous Injection General Anesthesia Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 30. Mexico Intravenous Injection General Anesthesia Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 31. Europe Intravenous Injection General Anesthesia Drugs Market Size by Country in 2025 Figure 32. Europe Intravenous Injection General Anesthesia Drugs Sales Market Share by Country (2021-2032) Figure 33. Europe Intravenous Injection General Anesthesia Drugs Revenue Market Share by Country (2021-2032) Figure 34. Germany Intravenous Injection General Anesthesia Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 35. France Intravenous Injection General Anesthesia Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 36. U.K. Intravenous Injection General Anesthesia Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 37. Italy Intravenous Injection General Anesthesia Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. Russia Intravenous Injection General Anesthesia Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. Spain Intravenous Injection General Anesthesia Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 40. Netherlands Intravenous Injection General Anesthesia Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 41. Switzerland Intravenous Injection General Anesthesia Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 42. Sweden Intravenous Injection General Anesthesia Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 43. Poland Intravenous Injection General Anesthesia Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 44. Asia Pacific Intravenous Injection General Anesthesia Drugs Market Size by Country in 2025 Figure 45. Asia Pacific Intravenous Injection General Anesthesia Drugs Sales Market Share by Country (2021-2032) Figure 46. Asia Pacific Intravenous Injection General Anesthesia Drugs Revenue Market Share by Country (2021-2032) Figure 47. China Intravenous Injection General Anesthesia Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 48. Japan Intravenous Injection General Anesthesia Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 49. South Korea Intravenous Injection General Anesthesia Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. India Intravenous Injection General Anesthesia Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 51. Australia Intravenous Injection General Anesthesia Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 52. Taiwan Intravenous Injection General Anesthesia Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 53. Southeast Asia Intravenous Injection General Anesthesia Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 54. Southeast Asia Intravenous Injection General Anesthesia Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 55. South America Intravenous Injection General Anesthesia Drugs Market Size by Country in 2025 Figure 56. South America Intravenous Injection General Anesthesia Drugs Sales Market Share by Country (2021-2032) Figure 57. South America Intravenous Injection General Anesthesia Drugs Revenue Market Share by Country (2021-2032) Figure 58. Brazil Intravenous Injection General Anesthesia Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 59. Argentina Intravenous Injection General Anesthesia Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 60. Chile Intravenous Injection General Anesthesia Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 61. Middle East and Africa Intravenous Injection General Anesthesia Drugs Market Size by Country in 2025 Figure 62. Middle East and Africa Intravenous Injection General Anesthesia Drugs Sales Market Share by Country (2021-2032) Figure 63. Middle East and Africa Intravenous Injection General Anesthesia Drugs Revenue Market Share by Country (2021-2032) Figure 64. Egypt Intravenous Injection General Anesthesia Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 65. South Africa Intravenous Injection General Anesthesia Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 66. Israel Intravenous Injection General Anesthesia Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 67. Türkiye Intravenous Injection General Anesthesia Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 68. GCC Countries Intravenous Injection General Anesthesia Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 69. Global Intravenous Injection General Anesthesia Drugs Sales Market Share by Type (2021-2032) Figure 70. Global Intravenous Injection General Anesthesia Drugs Revenue Market Share by Type (2021-2032) Figure 71. Global Intravenous Injection General Anesthesia Drugs Price (US$/unit) by Type (2021-2032) Figure 72. Global Intravenous Injection General Anesthesia Drugs Sales Market Share by Application (2021-2032) Figure 73. Global Intravenous Injection General Anesthesia Drugs Revenue Market Share by Application (2021-2032) Figure 74. Global Intravenous Injection General Anesthesia Drugs Price (US$/unit) by Application (2021-2032) Figure 75. Intravenous Injection General Anesthesia Drugs Value Chain Figure 76. Intravenous Injection General Anesthesia Drugs Production Mode & Process Figure 77. Direct Comparison with Distribution Share Figure 78. Distributors Profiles Figure 79. Intravenous Injection General Anesthesia Drugs Industry Opportunities and Challenges

Scope & coverage.

Types
  • Propofol
  • Sevoflurane
  • Remifentanil
  • Etomidate
  • Isoflurane
  • Other
Applications
  • Hopitals
  • Clinics
  • Others
Companies covered
  • Aspen Pharma
  • Hikma Pharmaceuticals
  • Maruishi
  • Maruishi
  • Piramal
  • AstraZeneca
  • AbbVie
  • Baxter Healthcare
  • B.Braun
  • Fresenius-Kabi
  • China National Medicines Guorui Pharmaceutical Co.,Ltd.
  • Hengrui
  • Nhwa
  • Lunan Pharmaceutical Group Corporation
  • Xi'an Libang
  • Yichang Humanwell

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Intravenous Injection General Anesthesia Drugs Market Size (2021-2032)
  4. 2.2.2 Global Intravenous Injection General Anesthesia Drugs Sales (2021-2032)
  5. 2.2.3 Global Intravenous Injection General Anesthesia Drugs Market Average Price (2021-2032)
  6. 2.3 Intravenous Injection General Anesthesia Drugs by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 Propofol
  9. 2.3.3 Sevoflurane
  10. 2.3.4 Remifentanil
  11. 2.3.5 Etomidate
  12. 2.3.6 Isoflurane
  13. 2.3.7 Other
  14. 2.4 Intravenous Injection General Anesthesia Drugs by Application
  15. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  16. 2.4.2 Hopitals
  17. 2.4.3 Clinics
  18. 2.4.4 Others
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Intravenous Injection General Anesthesia Drugs Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Intravenous Injection General Anesthesia Drugs Sales (k units) of Manufacturers (2021-2026)
  3. 3.3 Global Intravenous Injection General Anesthesia Drugs Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Intravenous Injection General Anesthesia Drugs Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Intravenous Injection General Anesthesia Drugs Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Intravenous Injection General Anesthesia Drugs, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Intravenous Injection General Anesthesia Drugs, Product Type & Application
  8. 3.8 Global Manufacturers of Intravenous Injection General Anesthesia Drugs, Established Date
  9. 3.9 Global Intravenous Injection General Anesthesia Drugs Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 Aspen Pharma
  2. 4.1.1 Aspen Pharma Company Information
  3. 4.1.2 Aspen Pharma Business Overview
  4. 4.1.3 Aspen Pharma Intravenous Injection General Anesthesia Drugs Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 Aspen Pharma Intravenous Injection General Anesthesia Drugs Product Portfolio
  6. 4.1.5 Aspen Pharma Recent Developments
  7. 4.2 Hikma Pharmaceuticals
  8. 4.2.1 Hikma Pharmaceuticals Company Information
  9. 4.2.2 Hikma Pharmaceuticals Business Overview
  10. 4.2.3 Hikma Pharmaceuticals Intravenous Injection General Anesthesia Drugs Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 Hikma Pharmaceuticals Intravenous Injection General Anesthesia Drugs Product Portfolio
  12. 4.2.5 Hikma Pharmaceuticals Recent Developments
  13. 4.3 Maruishi
  14. 4.3.1 Maruishi Company Information
  15. 4.3.2 Maruishi Business Overview
  16. 4.3.3 Maruishi Intravenous Injection General Anesthesia Drugs Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 Maruishi Intravenous Injection General Anesthesia Drugs Product Portfolio
  18. 4.3.5 Maruishi Recent Developments
  19. 4.4 Maruishi
  20. 4.4.1 Maruishi Company Information
  21. 4.4.2 Maruishi Business Overview
  22. 4.4.3 Maruishi Intravenous Injection General Anesthesia Drugs Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 Maruishi Intravenous Injection General Anesthesia Drugs Product Portfolio
  24. 4.4.5 Maruishi Recent Developments
  25. 4.5 Piramal
  26. 4.5.1 Piramal Company Information
  27. 4.5.2 Piramal Business Overview
  28. 4.5.3 Piramal Intravenous Injection General Anesthesia Drugs Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 Piramal Intravenous Injection General Anesthesia Drugs Product Portfolio
  30. 4.5.5 Piramal Recent Developments
  31. 4.6 AstraZeneca
  32. 4.6.1 AstraZeneca Company Information
  33. 4.6.2 AstraZeneca Business Overview
  34. 4.6.3 AstraZeneca Intravenous Injection General Anesthesia Drugs Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 AstraZeneca Intravenous Injection General Anesthesia Drugs Product Portfolio
  36. 4.6.5 AstraZeneca Recent Developments
  37. 4.7 AbbVie
  38. 4.7.1 AbbVie Company Information
  39. 4.7.2 AbbVie Business Overview
  40. 4.7.3 AbbVie Intravenous Injection General Anesthesia Drugs Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 AbbVie Intravenous Injection General Anesthesia Drugs Product Portfolio
  42. 4.7.5 AbbVie Recent Developments
  43. 4.8 Baxter Healthcare
  44. 4.8.1 Baxter Healthcare Company Information
  45. 4.8.2 Baxter Healthcare Business Overview
  46. 4.8.3 Baxter Healthcare Intravenous Injection General Anesthesia Drugs Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 Baxter Healthcare Intravenous Injection General Anesthesia Drugs Product Portfolio
  48. 4.8.5 Baxter Healthcare Recent Developments
  49. 4.9 B.Braun
  50. 4.9.1 B.Braun Company Information
  51. 4.9.2 B.Braun Business Overview
  52. 4.9.3 B.Braun Intravenous Injection General Anesthesia Drugs Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 B.Braun Intravenous Injection General Anesthesia Drugs Product Portfolio
  54. 4.9.5 B.Braun Recent Developments
  55. 4.10 Fresenius-Kabi
  56. 4.10.1 Fresenius-Kabi Company Information
  57. 4.10.2 Fresenius-Kabi Business Overview
  58. 4.10.3 Fresenius-Kabi Intravenous Injection General Anesthesia Drugs Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 Fresenius-Kabi Intravenous Injection General Anesthesia Drugs Product Portfolio
  60. 4.10.5 Fresenius-Kabi Recent Developments
  61. 4.11 China National Medicines Guorui Pharmaceutical Co.,Ltd.
  62. 4.11.1 China National Medicines Guorui Pharmaceutical Co.,Ltd. Company Information
  63. 4.11.2 China National Medicines Guorui Pharmaceutical Co.,Ltd. Business Overview
  64. 4.11.3 China National Medicines Guorui Pharmaceutical Co.,Ltd. Intravenous Injection General Anesthesia Drugs Sales, Revenue and Gross Margin (2021-2026)
  65. 4.11.4 China National Medicines Guorui Pharmaceutical Co.,Ltd. Intravenous Injection General Anesthesia Drugs Product Portfolio
  66. 4.11.5 China National Medicines Guorui Pharmaceutical Co.,Ltd. Recent Developments
  67. 4.12 Hengrui
  68. 4.12.1 Hengrui Company Information
  69. 4.12.2 Hengrui Business Overview
  70. 4.12.3 Hengrui Intravenous Injection General Anesthesia Drugs Sales, Revenue and Gross Margin (2021-2026)
  71. 4.12.4 Hengrui Intravenous Injection General Anesthesia Drugs Product Portfolio
  72. 4.12.5 Hengrui Recent Developments
  73. 4.13 Nhwa
  74. 4.13.1 Nhwa Company Information
  75. 4.13.2 Nhwa Business Overview
  76. 4.13.3 Nhwa Intravenous Injection General Anesthesia Drugs Sales, Revenue and Gross Margin (2021-2026)
  77. 4.13.4 Nhwa Intravenous Injection General Anesthesia Drugs Product Portfolio
  78. 4.13.5 Nhwa Recent Developments
  79. 4.14 Lunan Pharmaceutical Group Corporation
  80. 4.14.1 Lunan Pharmaceutical Group Corporation Company Information
  81. 4.14.2 Lunan Pharmaceutical Group Corporation Business Overview
  82. 4.14.3 Lunan Pharmaceutical Group Corporation Intravenous Injection General Anesthesia Drugs Sales, Revenue and Gross Margin (2021-2026)
  83. 4.14.4 Lunan Pharmaceutical Group Corporation Intravenous Injection General Anesthesia Drugs Product Portfolio
  84. 4.14.5 Lunan Pharmaceutical Group Corporation Recent Developments
  85. 4.15 Xi'an Libang
  86. 4.15.1 Xi'an Libang Company Information
  87. 4.15.2 Xi'an Libang Business Overview
  88. 4.15.3 Xi'an Libang Intravenous Injection General Anesthesia Drugs Sales, Revenue and Gross Margin (2021-2026)
  89. 4.15.4 Xi'an Libang Intravenous Injection General Anesthesia Drugs Product Portfolio
  90. 4.15.5 Xi'an Libang Recent Developments
  91. 4.16 Yichang Humanwell
  92. 4.16.1 Yichang Humanwell Company Information
  93. 4.16.2 Yichang Humanwell Business Overview
  94. 4.16.3 Yichang Humanwell Intravenous Injection General Anesthesia Drugs Sales, Revenue and Gross Margin (2021-2026)
  95. 4.16.4 Yichang Humanwell Intravenous Injection General Anesthesia Drugs Product Portfolio
  96. 4.16.5 Yichang Humanwell Recent Developments
5 Global Intravenous Injection General Anesthesia Drugs Market Scenario by Region
  1. 5.1 Global Intravenous Injection General Anesthesia Drugs Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Intravenous Injection General Anesthesia Drugs Sales by Region: 2021-2032
  3. 5.2.1 Global Intravenous Injection General Anesthesia Drugs Sales by Region: 2021-2026
  4. 5.2.2 Global Intravenous Injection General Anesthesia Drugs Sales by Region: 2027-2032
  5. 5.3 Global Intravenous Injection General Anesthesia Drugs Revenue by Region: 2021-2032
  6. 5.3.1 Global Intravenous Injection General Anesthesia Drugs Revenue by Region: 2021-2026
  7. 5.3.2 Global Intravenous Injection General Anesthesia Drugs Revenue by Region: 2027-2032
  8. 5.4 North America Intravenous Injection General Anesthesia Drugs Market Facts & Figures by Country
  9. 5.4.1 North America Intravenous Injection General Anesthesia Drugs Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Intravenous Injection General Anesthesia Drugs Sales by Country (2021-2032)
  11. 5.4.3 North America Intravenous Injection General Anesthesia Drugs Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.4.6 Mexico
  15. 5.5 Europe Intravenous Injection General Anesthesia Drugs Market Facts & Figures by Country
  16. 5.5.1 Europe Intravenous Injection General Anesthesia Drugs Market Size by Country: 2021 VS 2025 VS 2032
  17. 5.5.2 Europe Intravenous Injection General Anesthesia Drugs Sales by Country (2021-2032)
  18. 5.5.3 Europe Intravenous Injection General Anesthesia Drugs Revenue by Country (2021-2032)
  19. 5.5.4 Germany
  20. 5.5.5 France
  21. 5.5.6 U.K.
  22. 5.5.7 Italy
  23. 5.5.8 Russia
  24. 5.5.9 Spain
  25. 5.5.10 Netherlands
  26. 5.5.11 Switzerland
  27. 5.5.12 Sweden
  28. 5.5.13 Poland
  29. 5.6 Asia Pacific Intravenous Injection General Anesthesia Drugs Market Facts & Figures by Country
  30. 5.6.1 Asia Pacific Intravenous Injection General Anesthesia Drugs Market Size by Country: 2021 VS 2025 VS 2032
  31. 5.6.2 Asia Pacific Intravenous Injection General Anesthesia Drugs Sales by Country (2021-2032)
  32. 5.6.3 Asia Pacific Intravenous Injection General Anesthesia Drugs Revenue by Country (2021-2032)
  33. 5.6.4 China
  34. 5.6.5 Japan
  35. 5.6.6 South Korea
  36. 5.6.7 India
  37. 5.6.8 Australia
  38. 5.6.9 Taiwan
  39. 5.6.10 Southeast Asia
  40. 5.7 South America Intravenous Injection General Anesthesia Drugs Market Facts & Figures by Country
  41. 5.7.1 South America Intravenous Injection General Anesthesia Drugs Market Size by Country: 2021 VS 2025 VS 2032
  42. 5.7.2 South America Intravenous Injection General Anesthesia Drugs Sales by Country (2021-2032)
  43. 5.7.3 South America Intravenous Injection General Anesthesia Drugs Revenue by Country (2021-2032)
  44. 5.7.4 Brazil
  45. 5.7.5 Argentina
  46. 5.7.6 Chile
  47. 5.8 Middle East and Africa Intravenous Injection General Anesthesia Drugs Market Facts & Figures by Country
  48. 5.8.1 Middle East and Africa Intravenous Injection General Anesthesia Drugs Market Size by Country: 2021 VS 2025 VS 2032
  49. 5.8.2 Middle East and Africa Intravenous Injection General Anesthesia Drugs Sales by Country (2021-2032)
  50. 5.8.3 Middle East and Africa Intravenous Injection General Anesthesia Drugs Revenue by Country (2021-2032)
  51. 5.8.4 Egypt
  52. 5.8.5 South Africa
  53. 5.8.6 Israel
  54. 5.8.7 Türkiye
  55. 5.8.8 GCC Countries
6 Segment by Type
  1. 6.1 Global Intravenous Injection General Anesthesia Drugs Sales by Type (2021-2032)
  2. 6.1.1 Global Intravenous Injection General Anesthesia Drugs Sales by Type (2021-2032) & (k units)
  3. 6.1.2 Global Intravenous Injection General Anesthesia Drugs Sales Market Share by Type (2021-2032)
  4. 6.2 Global Intravenous Injection General Anesthesia Drugs Revenue by Type (2021-2032)
  5. 6.2.1 Global Intravenous Injection General Anesthesia Drugs Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Intravenous Injection General Anesthesia Drugs Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Intravenous Injection General Anesthesia Drugs Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Intravenous Injection General Anesthesia Drugs Sales by Application (2021-2032)
  2. 7.1.1 Global Intravenous Injection General Anesthesia Drugs Sales by Application (2021-2032) & (k units)
  3. 7.1.2 Global Intravenous Injection General Anesthesia Drugs Sales Market Share by Application (2021-2032)
  4. 7.2 Global Intravenous Injection General Anesthesia Drugs Revenue by Application (2021-2032)
  5. 7.2.1 Global Intravenous Injection General Anesthesia Drugs Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Intravenous Injection General Anesthesia Drugs Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Intravenous Injection General Anesthesia Drugs Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Intravenous Injection General Anesthesia Drugs Value Chain Analysis
  2. 8.1.1 Intravenous Injection General Anesthesia Drugs Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Intravenous Injection General Anesthesia Drugs Production Mode & Process
  5. 8.2 Intravenous Injection General Anesthesia Drugs Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Intravenous Injection General Anesthesia Drugs Distributors
  8. 8.2.3 Intravenous Injection General Anesthesia Drugs Customers
9 Global Intravenous Injection General Anesthesia Drugs Analyzing Market Dynamics
  1. 9.1 Intravenous Injection General Anesthesia Drugs Industry Trends
  2. 9.2 Intravenous Injection General Anesthesia Drugs Industry Drivers
  3. 9.3 Intravenous Injection General Anesthesia Drugs Industry Opportunities and Challenges
  4. 9.4 Intravenous Injection General Anesthesia Drugs Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst